Skip to main content

Table 4 Baseline LD and SUVmax summary in patients with ≥ 1 evaluable time point assessment of 18FDG-PET avidity

From: Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone

 

n

Mean

SD

Min

Q1

Median

Q3

Max

LD, mm

174

68.4

40.8

10.0

38.0

62.5

91.0

283.0

SUVmax

26

11.1

4.7

3.8

7.9

10.6

13.6

21.6

  1. 18FDG-PET 2-deoxy-2-[18F]-fluorodeoxyglucose positron emission tomography, LD longest diameter, max maximum, min minimum, Q quartile, SUVmax maximum standardized uptake value
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us